Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Adrenocortical Carcinoma

Below is an extended Adrenocortical Carcinoma research listing. Click here to return to the Adrenocortical Carcinoma main in depth entry.

Recent Publications on Adrenocortical Carcinoma:

[Adrenocortical carcinoma with intratumoral hemorrhage detected from chest and back pain: a case report.] 18th November, 2009
The Department of Urology, Tane General Hospital.
Chemopreventive actions by enterolactone and 13 VIOXX(R)-related lactone derivatives in H295R human adrenocortical carcinoma cells.
Cytochrome P450c17 (CYP17) has been linked to various hormone-related...
Direct Link
17th November, 2009
Endocrine Toxicology, Institute for Risk Assessment Sciences, Utrecht
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
AIMS: Pathological diagnosis of adrenocortical carcinoma relies on several...
Direct Link
17th November, 2009
Division of Pathology, Department of Clinical and Biological Sciences,
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.
Objective: No standard therapy for advanced adrenocortical carcinoma (ACC)...
Direct Link
12th November, 2009
S Wortmann, Dept. of Medicine I, University of Wurzburg, University
Biphasic hormonal responses to the adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE in human cells.
The DDT metabolite 3-methylsulfonyl-DDE (3-MeSO(2)-DDE) has been proposed...
Direct Link
11th November, 2009
Department of Environmental Toxicology, Uppsala University, Norbyvagen 18
Medical management of adrenal disease: a narrative review. 7th November, 2009
Department of Endocrinology, E Venizelou Hospital, 2, Athens GR-11521,
[Recent data in adrenocortical tumorigenesis]
Adrenocortical carcinomas are rare tumors characterized by an aggressive...
Direct Link
3rd November, 2009
Federation d'endocrinologie du pole Est, Hospices Civils de Lyon, 59,
Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
Abstract A role of beta-catenin (CTNNB1) in the molecular pathogenesis of...
Direct Link
30th October, 2009
1 Faculty of Science, Prince of Songkla University.
Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane.
BACKGROUND: A recent nonrandomized interinstitutional study reported that...
Direct Link
24th October, 2009
Department of Surgical Oncology, The University of Texas M.D. Anderson
Adrenocortical cancer.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy causing up...
Direct Link
20th October, 2009
Translational Genomics Research Institute, Clinical Translational Research
Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
The adrenal gland is involved by a range of neoplasms, including primary...
Direct Link
16th October, 2009
Russell H. Morgan Department of Radiology and Radiologic Science, Johns
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy causing up...
Direct Link
15th October, 2009
Department of Surgical Oncology, The University of Texas M. D. Anderson
Reply to Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy causing up...
Direct Link
15th October, 2009
Department of Internal Medicine I, Endocrine and Diabetes Unit, University
The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.
CONTEXT: Adrenocortical carcinoma (ACC) is a rare tumor with a poor...
Direct Link
13th October, 2009
Cancer Genetics Unit, Hormones and Cancer Group, Kolling Institute of
Development of microemulsion of mitotane for improvement of oral bioavailability.
Background: Mitotane (o,p'-DDD) is considered to be the drug of choice in...
Direct Link
26th September, 2009
Laboratoire de Pharmacie Clinique, Nancy Universite, Nancy, France.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.